LEADER 01924nam  2200445 a 450 
001 9910701863003321
005 20120911151115.0
035   $a(CKB)5470000002421477
035   $a(OCoLC)794596616
035   $a(EXLCZ)995470000002421477
100   $a20120601d2012      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBioterrorism, controlled substances, and public health issues$b[electronic resource] $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 21, 2011
210  1$aWashington :$cU.S. G.P.O.,$d2012.
215   $a1 online resource (iv, 150 pages)
300   $aTitle from title screen (viewed on June 1, 2012).
300   $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O.
300   $a"Serial no. 112-79."
320   $aIncludes bibliographical references.
517   $aBioterrorism, controlled substances, and public health issues 
606   $aEmergency management$xLaw and legislation$zUnited States
606   $aEmergency medical services$xLaw and legislation$zUnited States
606   $aHealth planning$xLaw and legislation$zUnited States
606   $aDesigner drugs$xLaw and legislation$zUnited States
606   $aMedicine$xResearch$xLaw and legislation$zUnited States
615  0$aEmergency management$xLaw and legislation
615  0$aEmergency medical services$xLaw and legislation
615  0$aHealth planning$xLaw and legislation
615  0$aDesigner drugs$xLaw and legislation
615  0$aMedicine$xResearch$xLaw and legislation
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701863003321
996   $aBioterrorism, controlled substances, and public health issues$93519678
997   $aUNINA